CMRA — Comera Life Sciences Holdings Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$1.76m
- $0.63m
Brief: Comera Life Sciences Announces Process Exploring Strategic Alternatives
Brief: Comera Life Sciences Holdings - On Nov 15, Got Notice From Nasdaq That Nasdaq Hearings Panel Has Determined To Delist Common Stock And Warrants Of Co
Brief: Comera Life Sciences Appoints Dorothy Clarke To Board Of Directors
Brief: Comera Life Sciences Announces Completion Of $4.1 Million Private Placement
Brief: Comera Life Sciences- Files Prospectus Related To Offer, Resale From Time To Time By Selling Stockholders Of Upto 27.9 Million Shares Of Common Stock
Brief: Comera Life Sciences Announces Publication Of Study Reinforcing Caffeine’S Viscosity Reducing Capabilities
Brief: Comera Life Sciences Q2 EPS USD -0.08
Brief: Comera Life Sciences Expands Intellectual Property Portfolio Strengthening Proprietary SQore Platform
Brief: Comera Life Sciences Announces Collaboration With Quality Chemical Laboratories
Brief: Comera Life Sciences - On May 18, Co Got Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard Transfer Of Listing From Nasdaq
Brief: Comera Life Sciences Holdings Receives Notice Of From Nasdaq
Brief: Comera Life Sciences Reports Financial Results For Fourth Quarter And Recent Business Highlights
Brief: Comera Life Sciences Files Prospectus Related To Offer And Resale By Selling Stockholders Of Up To 7.2 Million Shares Of Common Stock
Brief: Comera Life Sciences Reports Third Quarter Results
Brief: Comera Life Sciences Appoints Janice Marie Mccourt As Chief Business Officer
Brief: Comera Life Sciences Announces Favorable Preclinical Results Of Lead Sqore Excipient In Sequrus-2 Study
U.S. STOCKS ON THE MOVE-Applied Optoelectronics, Shoals Technologies, Intellia
U.S. STOCKS ON THE MOVE-Dow Inc, Corteva, Marker Therapeutics
Brief: Comera Life Sciences Holdings Files Prospectus Related To Potential Resale Of Up To 5 Million Shares Of Co By Selling Stockholder